Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here. -- Barrons.com
Price Over Earnings Overview: Eli Lilly
Market Whales and Their Recent Bets on LLY Options
Eli Lilly Q1 2025 Earnings Preview
Market Rally at Risk as Tariffs Damage Spreads. -2-
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
ELI LILLY Earnings Preview: Recent $LLY Insider Trading, Hedge Fund Activity, and More
Sector Update: Consumer Stocks Rise in Late Afternoon
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Eli Lilly and Company's (NYSE:LLY) P/E Still Appears To Be Reasonable
WW International Partners With LillyDirect Pharmacy Provider to Support Members in Getting Zepbound Vials
Express News | Creyon Bio: Will Receive a $13 Mln Upfront Payment
Express News | Creyon Bio and Lilly Enter Into Rna-Targeted Oligo Therapy Development Collaboration
WeightWatchers Rises on Partnership With Eli Lilly to Enhance Zepbound Access
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Hims & Hers Stock Soars. Why a Deal With Novo Nordisk for Weight-Loss Drugs Matters. -- Barrons.com
Hims & Hers' Stock Rockets After Teaming up With Its Rival Wegovy Maker
Is Eli Lilly and Company (LLY) the Best Long-Term Dividend Stock to Buy According to Billionaires?
Wells Fargo Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100